MEA Optogenetics Market

MEA Optogenetics Market Size (2024 to 2029)

The Optogenetics Market size in the Middle East & Africa was worth USD 2.56 billion in 2024 and estimated to reach USD 5.13 Billion by the end of 2029, registering a CAGR of 14.932% between 2024 to 2029.

Optogenetics is an emerging medical technique that allows genetically defined populaces of neurons to be controlled using light, enabling the study of normal and abnormal brain function characteristics. The market growth for this technique is rapidly increasing as it can be applied to develop new methods to treat various illnesses such as neurological disorders, hearing impairment, and retinal diseases.

Extensive research on optogenetics is being conducted in cardiology, behavioral science, neuroscience, and ophthalmology. Optogenetics is an emerging field of biotechnology. The development of improved gene-editing techniques will boost optogenetics and make it more proper for clinical applications. The opportunities for development in optogenetics tools and neuroscience are driving the growth of the global optogenetics market.

Factors such as the growth of technology like LEDs, ytterbium-based lasers, ultrafast laser tools, and the increasing number of labs worldwide have resulted in the extensive adoption and application of this technique. However, Optogenetics has a very stable and steady market because of its heavy demand as a diagnostic tool in neuroscience.

The market's growth is expected to be held back by factors such as expensive technology, lack of awareness of these tools in developing countries, and reluctance to adopt new technology by the healthcare industry.

This research report on the Middle East and Africa Optogenetics Market has been segmented & sub-segmented into the following categories

MEA Optogenetics Market By Sensor Type

• Genetically Encoded Calcium Indicators
• pH Sensors
• Neurotransmitter Release
• Voltage-Sensitive Fluorescent Proteins

MEA Optogenetics Market By Techniques

• Archaerhodopsin
• Channelrhodopsin
• Halorhodopsin

MEA Optogenetics Market By Application

• Retinal Disease Treatment
• Cardioversion
• Neuroscience
• Behavioral Tracking and Pacing

MEA Optogenetics Market By Light Equipment

• Lasers
• LEDs
• Others

MEA Optogenetics Market By Country

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East and Africa are expected to account for a moderate share in the global optogenetics market during the forecast period. The regional market growth is driven by the proliferation of neurological disorders and the opportunities in the tools related to optogenetics, as the tools have bidirectional control over the neural activities present in an extensive network.

The UAE optogenetics market is estimated to see an attractive growth rate during the forecast period due to the growing demand and need for diagnostic tools. These tools of optogenetics include a variety of light-sensitive proteins used to regulate intracellular signaling via g-protein. In addition, availability of advanced healthcare, improving healthcare sector, and increasing healthcare spending.

The Saudi Arabian optogenetics market is forecasted to have an impressive growth rate during the forecast period due to the growing awareness and initiatives from government and non-government firms in research activities for effective treatment and procedures in neurosciences are possessing the growth in the optogenetics market.

The South African optogenetics market is predicted to witness a healthy CAGR due to advancement and development in technology, with the rise in the use of optogenetics is increasing the demand for market growth.

KEY MARKET PLAYERS

Coherent Inc., Noldus, Thorlabs Inc., Cobalt Inc., Scientifica, Bruker, Laserglow technologies, Regenxbio Inc., Gensight, Addgene, UPenn Vector Core, and Jackson Laboratories are playing a leading role in the MEA Optogenetics Market.